Dermal preparations formulation

Encapsulated dia2innon sold as Knox-Out 2FM is a commercial encapsulated pesticide formulation said to have reduced dermal and oral toxicity as well as prolonged effectiveness. The capsules, prepared by interfacial polymeri2ation, are claimed to be highly effective against cockroaches with no objectionable odor and low insect repeUence. The capsules are beheved to function as a contact poison when insects walk on it and as a stomach poison when insects preen capsules stuck to their legs and ingest them (71). 

Field fortifications were prepared to check the field/storage stability of the dermal dosimeters, handwashes, and air filters. The field fortifications were prepared using the formulated product undiluted for "high" level spikes and diluted with water (-1 pg/mL chlorpyrifos) for the "low" level field spikes. Field fortification solutions for urine were prepared from a 3,5,6-TCP standard in acetonitrile utilizing an 1.2-pg/mL solution for the "high" field fortifications and an -0.01-ug/mL solution for the "low" level fortifications. 

The generally low lipid content and the poor viscosity of lipid nanodispersions make these preparations, as they are, less suitable for dermal drug application. The handling of the preparation by the patient is improved by SLN incorporation into ointments, creams, and gels. Alternatively, ready-to-use preparations may be obtained by one-step production, increasing the lipid phase to at least 30%. However, increasing the lipid frequently results in an unwanted increase in particle size. Surprisingly, it has been found that very concentrated (30 to 40%) semisolid cetyl palmitate formulations preserve the colloidal particle size [10]. 

Furhman, L., et al. 1995. Evaluation of several liposomal formulations and preparation techniques for the dermal delivery of phosphorothioate antisense oligonucleotides in hairless mouse skin in vitro. In AAPS Annual Meeting, Miami Beach, FL, USA. 

Laurie acid is widely used in cosmetic preparations, in the manufacture of food-grade additives, and in pharmaceutical formulations. General exposure to lauric acid occurs through the consumption of food and through dermal contact with cosmetics, soaps, and detergent products. Lauric acid is toxic when administered intravenously. 

Cisplatin is only available for intravenous use. It is generally supplied in vials as a solution or as a lyophilized powder. The possibility exists for dermal, oral, or inhalation exposure during production, and during preparation of dosing formulations. 

In the case of dermal exposure, the contaminated area must be washed with plenty of water and soap. Topical application of vitamin E preparations may help to reduce the severity of skin reactions. The affected eye must be irrigated with lukewarm water for at least 10 min. The contaminated clothing is removed and the airway cleared. In the case of ingestion, gastric lavage is avoided as solvents present in cyfluthrin formulations may increase the risk of aspiration pneumonia. Atropine (adults and children >12 years 0.6-1.2mgkg children <12 years 0.02 mg kg by IV infusion) may be useful to... 

Lip Eyelid formula is a phenol peel that I first developed to increase dermatological safety and to achieve results without any occlusion on the sensitive skin of the eyelids. The same solution was then applied to the wrinkles around the mouth and then to the whole face, but with 24 hours occlusion in these two indications. It is an oil solution of phenol at over 60%. Four different oils are used in the various stages of the product s preparation. The aim of the oily formulation is to slow down the penetration of the phenol through the skin and to improve dermal and epidermal maceration. It limits the toxicity of phenol by saturating the biochemical hepatic detoxification pathways more slowly. 

It is also apparent that little effort is made to optimize the vehicle for topically administered sensitizers (e.g., dermal, oral cavity). For such applications, one is frequently presented to simple aqueous solutions of ethanol or DMSO. Topical preparations thereby offer a challenge to the formulation expert. Application to the oral cavity and larynx would benefit from bioadhesive formulations to increase the contact time between sensitizer and tissue. A well-designed vehicle could allow topical administration of sensitizers to tumors located close to the skin surface and thus offer an alternative to the present systemic administration. 

Preparations for cutaneous (or dermal) application may be used for local treatment as well as for transdermal administration with a systemic effect. The chapter focuses on preparations with a local effect and on design of formulation and method of preparation of those prepared in pharmacies. The interaction between skin, active substance and base, the anatomy of the skin and biopharmaceutical aspects of cutaneous preparations are discussed as well as the therapeutic effect of the base. Because of the important role of the pharmacist in prescription assessment some recommendations for the communication with the physician are given. One aspect is how to proceed with a request for the mixing of two licensed medicines or for the addition of an active substance or an excipient to a licensed product. The formulation design is generally following the several phases of the multicomponent preparations. Based on the... 

Cutaneous preparatimis are inefficient formulations since only small amounts of the applied active substance penetrate the skin and reach the site of action. The first attempts to understand the mechanism of skin permeation and formulation effects of cutaneous preparations were described in 1960 [10]. Since then more research has been performed on rational design of dermal formulations. Much research is focused on improved skin penetration [11, 12]. Skin... 

The cosmetics and transdermal drug delivery fields are also expected to further benefit from the formulation of microemulsions from mild sugarbased surfactants. Lehmann et al. have studied the effect of such a microemulsion on dermal and corneal irritation, and hydrocortisone incorporation [105]. A microemulsion containing commercially available sucrose esters, isopropyl myristate, and propylene glycol and water was prepared as a water continuous system, and 16.5% hydrocortisone was loaded into the anhydrous base mixture. The formulation spread well on the skin due to the low surface tension of the system at 26 mN/m. While the microemulsion provided greater drug penetration, it also resulted in irritation and barrier compromise. The authors make the point that the formulation may be better suited to drugs that do not induce an irritation themselves. 

---